A detailed history of Motley Fool Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Motley Fool Wealth Management, LLC holds 41,240 shares of VRTX stock, worth $21.3 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
41,240
Previous 42,074 1.98%
Holding current value
$21.3 Million
Previous $17.6 Million 9.91%
% of portfolio
1.05%
Previous 0.98%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $327,603 - $404,932
-834 Reduced 1.98%
41,240 $19.3 Million
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $17.2 Million - $18.8 Million
42,074 New
42,074 $17.6 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Motley Fool Wealth Management, LLC Portfolio

Follow Motley Fool Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.